Considerations of meropenem dosage for bacterial meningitis based on pharmacodynamics in cerebrospinal fluid.
Kazuro
K
Ikawa
Norifumi
N
Morikawa
Kayo
K
Ikeda
Ryu
R
Tsumura
Masaaki
M
Shibukawa
Koji
K
Iida
Kaoru
K
Kurisu
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001419:Bacteria / Q000187:drug effects; D002555:Cerebrospinal Fluid / Q000737:chemistry*; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy*; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D013845:Thienamycins / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem